新型冠状病毒血清学检测当前进展综述
所有主要SARS-CoV-2抗原均具诊断价值,总抗体检测灵敏度最高,IgM与IgG联合检测灵敏度高于单一抗体检测。血清学检测联合逆转录聚合酶链反应可显著提高SARS-CoV-2感染者的检出灵敏度,但抗体滴度与临床严重程度的相关性证据不一致。
要点
- 总抗体检测灵敏度最高,IgM与IgG联合检测优于单一抗体检测。
- 血清学联合RT-PCR可显著提高SARS-CoV-2感染检出灵敏度。
- 部分免疫测定或可替代预测中和抗体滴度及筛选康复者血浆捐献。
核心结论
- 血清学检测联合逆转录聚合酶链反应可显著提高SARS-CoV-2感染者的检出灵敏度。
- 抗体滴度与临床严重程度的相关性证据不一致。
- 初步研究提示部分免疫测定或可替代预测中和抗体滴度及筛选康复者血浆捐献。
研究设计与样本
- 文献综述,检索PubMed、medRxiv和bioRxiv数据库。
主要发现
- 纳入研究包括侧向流免疫测定、酶联免疫吸附测定、化学发光免疫测定和中和抗体测定。
- 所有主要SARS-CoV-2抗原均被证明具有诊断价值。
- 测量总抗体反应性的测定灵敏度最高。
- 所有方法均可通过抗体同种型表征体液免疫反应。
- IgM与IgG联合检测的灵敏度高于单独检测任一抗体。
关键数值与推荐
- IgA虽研究较少,但被证明是敏感的感染标志物,其水平与疾病严重程度和中和活性相关。
- 所有主要SARS-CoV-2抗原均具诊断价值;总抗体检测灵敏度最高;IgM与IgG联合检测灵敏度高于单一抗体检测。
临床怎么用
- 血清学检测应与逆转录聚合酶链反应联合使用以提高SARS-CoV-2感染检出灵敏度。
- IgM与IgG联合检测可提高血清学检测灵敏度。
- 部分免疫测定或可用于预测中和抗体滴度及筛选康复者血浆捐献。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine and summarize the current literature on serologic methods for the detection of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: A literature review was performed using searches in databases including PubMed, medRxiv, and bioRxiv. Thirty-two peer-reviewed papers and 23 preprints were examined. RESULTS: The studies included lateral flow immunoassay, enzyme-linked immunosorbent assay, chemiluminescence immunoassay, and neutralizing antibody assays. The use of all major SARS-CoV-2 antigens was demonstrated to have diagnostic value. Assays measuring total antibody reactivity had the highest sensitivity. In addition, all the methods provided opportunities to characterize the humoral immune response by isotype. The combined use of IgM and IgG detection resulted in a higher sensitivity than that observed when detecting either isotype alone. Although IgA was rarely studied, it was also demonstrated to be a sensitive marker of infection, and levels correlated with disease severity and neutralizing activity. CONCLUSIONS: The use of serologic testing, in conjunction with reverse transcription polymerase chain reaction testing, was demonstrated to significantly increase the sensitivity of detection of patients infected with SARS-CoV-2. There was conflicting evidence regarding whether antibody titers correlated with clinical severity. However, preliminary investigations indicated some immunoassays may be a surrogate for the prediction of neutralizing antibody titers and the selection of recovered patients for convalescent serum donation.
引用
- Espejo AP, Akgun Y, Al Mana AF, et al. Review of Current Advances in Serologic Testing for COVID-19. Am J Clin Pathol. 2020. PMID: 32583852. doi:10.1093/ajcp/aqaa112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。